Africa (WHO region) vs Niger: Hepatitis B surface antigen (HBsAg) prevalence (%)
Africa (WHO region)
1.4%
in 2024
Niger
3.2%
in 2024
Africa (WHO region) rank
1st
Niger rank
3rd
Hepatitis B surface antigen (HBsAg) prevalence (%) over time
- Africa (WHO region)
- Niger
How they compare
Niger currently reports 3.2% against 1.4% in Africa (WHO region), a difference of 1.8%.
That makes Niger's figure about 2.3 times Africa (WHO region)'s.
Across all 10 years both countries report, Niger has been ahead every year.
Africa (WHO region) ranks 1st and Niger ranks 3rd of 13 groups.
Niger has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Africa (WHO region) | Niger | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1.9% | 2.6% | 0.7% | Niger |
| 2020s | 1.6% | 3.4% | 1.9% | Niger |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Africa (WHO region) or Niger?
- Niger, at 3.2% against 1.4% in Africa (WHO region) as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Africa (WHO region) and Niger?
- 1.8%, with Niger ahead.
- How many years of comparable data are there for Africa (WHO region) and Niger?
- 10 years are reported by both, from 2015 to 2024.
- How do Africa (WHO region) and Niger rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Africa (WHO region) ranks 1st and Niger ranks 3rd of 13 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.